In this case, the pill, called VXA-G1.1-NN, has been designed to deliver a harmless viral vector carrying a norovirus protein directly to the small intestine. This is not the only norovirus vaccine ...

EQS-News: GeoVax, Inc. / Key word (s): Financial GeoVax Labs Announces $4.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules 24.03.2025 / 13:05 CET/CEST The issuer is ...

Five years ago, on March 11, the World Health Organization declared COVID-19 a global pandemic. The vaccines “underwent the most intensive safety analysis in U.S. history." ...

Here is everything you need to know about the recent case of human coronavirus case in Kolkata. Understanding the symptoms of ...

The researchers reviewed data on symptom severity and COVID-19 vaccination status. Significantly more cancer survivors had ...

Hyderabad: Bharat Biotech International Limited (BBIL), has announced the launch of India's only vertically integrated, ...

Apriori Bio has become the latest Flagship Pioneering-backed biotech to shed staff, cutting 15 workers to leave 21 still ...

Bharat Biotech invests $75 million in India's first Cell & Gene Therapy facility, focusing on advanced therapies and ...

Transgene’s programs utilize viral vector technology with the goal of indirectly or directly killing cancer cells. The Company’s clinical-stage programs consist of a portfolio of therapeutic vaccines ...

BBIL's 50,000-square-foot CGT facility advances its mission to deliver life-saving treatments for haematological malignancies ...

has been designed to deliver a harmless viral vector carrying a norovirus protein directly to the small intestine. This is not the only norovirus vaccine currently in trials – for example ...

Our Bureau, Bengaluru Thursday, March 20, 2025, 17:40 Hrs [IST] ...